Cancer treatment works best when it is guided by the right information. OncoTarget® by 1Cell.Ai is a targeted genomic testing solution designed to identify key mutations across major cancers including Lung, Breast, Colorectal, Ovarian, Prostate, Bladder, and more. Unlike broad, expensive genomic panels, OncoTarget® focuses only on clinically actionable genes recommended by global guidelines such as NCCN, ASCO, and ESMO, making precision oncology affordable and accessible across India’s healthcare settings.
For oncologists, OncoTarget® delivers fast, easy-to-read reports powered by the iCare AI platform, helping you make confident therapy decisions without getting lost in unnecessary data. The panel can be customized with up to 20 disease-specific genes, works with both tissue and blood samples, and includes optional PD-L1 expression testing. For patients, it means getting the right treatment sooner, without the burden of high testing costs.
Download our whitepaper to explore the science, clinical evidence, and real-world application behind OncoTarget®. Understand how targeted genomic testing can change the course of your cancer care journey, whether you are a clinician looking to enhance your practice or a patient seeking clarity on your treatment options.